| 标题 |
PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:J. Buteau; A. Martin; L. Emmett; A. Iravani; S. Sandhu; et al 出版日期:2022-10-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)